Filter
99
Text search:
remdesivir
Featured
Recommendations
31
New Publications
6
Language
Document type
Guidelines
55
Fact sheets
14
Studies & Reports
10
No document type
7
Manuals
4
Training Material
3
Resource Platforms
3
Infographics
1
Videos
1
Strategic & Response Plan
1
Countries / Regions
Germany
10
Brazil
8
Latin America and the Carribbean
8
Mozambique
6
Angola
6
Guinea-Bissau
4
Uganda
4
India
4
Rwanda
4
Congo, Democratic Republic of
3
South Sudan
3
Liberia
2
China
2
South Africa
2
Peru
2
Ecuador
2
Paraguay
2
Russia
2
Global
2
Spain
2
Kenya
1
Tanzania
1
Thailand
1
Argentina
1
Austria
1
Switzerland
1
Ukraine
1
Chile
1
East and Southern Africa
1
Africa
1
France
1
Authors & Publishers
Publication Years
Category
Countries
53
Pharmacy & Technologies
2
Public Health
1
Clinical Guidelines
1
Women & Child Health
1
Key Resources
1
Toolboxes
COVID-19
79
Ebola & Marburg
10
Pharmacy
5
Conflict
1
HIV
1
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional
...
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended
To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo
...
COVID Reference 2020.3 DEU
recommended
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients
...
A elaboração das Diretrizes para Diagnóstico e Tratamento da COVID-19 é uma resposta rápida ao enfrentamento da COVID-19, diante da declaração de pandemia pela Organização Mundial de Saúde (OMS) e das iniciativas do Ministério da Saúde para enfrentamento dessa nova situação no Brasil.
...
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi
...
(7th Version)
20, March 2020
Dexametasona para tratamento de pacientes com COVID-19
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de
...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
